Guidance for Industry - Product Monographs of Non-Contraceptive Estrogen/Progestin-Containing Products

Health Canada initiated a Hormone Replacement Therapy (HRT) class labelling project in light of new safety information derived from the results of the Women's Health Initiative (WHI) trial and the Women's Health Initiative Memory Study (WHIMS). This document is intended to help the pharmaceutical industry revise the content of the Product Monograph and associated labelling materials.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data